Vaxcyte
PCVX
Vaxcyte (PCVX) news
Recent news
Vaxcyte - expects top-line data from Vax-A1 Phase 1 study in H2 2027
AInvest Wire · Jun 2, 2026BauCo adds Aon, V, TFX, NCLH, PCVX in 1Q: 13F
AInvest Wire · May 14, 2026ImportantVaxcyte reports positive topline data from Phase 1/2 study
AInvest Wire · Sep 3, 2024Vaxcyte offering of 10.9m shares at $64 each
AInvest Wire · Jan 31, 2024ImportantVaxcyte is said to offer $500M of shares at $64/shr fixed price - Bloomberg
AInvest Wire · Jan 30, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.